Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials. Although both studies will enroll 25 patients initially, the U.S. In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s not clear whether the Department of Health will provide the data.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Veriheal

FEBRUARY 21, 2023

” Restricting qualifying conditions also results in limited data collection, hindering the collective understanding of medical cannabis. Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

The Cannigma

NOVEMBER 1, 2023

And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains. That’s why Kriva is recruiting 150 Cannigma readers to try the Daily Wellness Body Lotion and report back on their experiences over a 4-week data collection period.

Topical 82

Topical Data Terpenes Cannabinoids 82

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis Front. 12 September 2018.

Epilepsy 72

Epilepsy Extraction Treatment CBD 72

TheAnswerPage

JULY 18, 2022

In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A.

Epilepsy 52

Epilepsy Therapy Extraction Treatment 52

Cannabis Law Report

JULY 24, 2019

It will be the first to have meaningful and consistent data of how medicinal cannabis has helped when properly prescribed as part of a full treatment pathway.”

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

LifeCannMD

JANUARY 2, 2024

Florida Epilepsy Patients : CBD blocks the ability of LPI to amplify nerve signals in a brain region and has been known to reduce the frequency and severity of seizures in epilepsy. Some animal-based studies go as far as to suggest cannabinoids might slow cancer cell growth.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

Cannabis Law Report

AUGUST 10, 2021

Commenting on the MHRA approval of GW’s cannabidiol, Tuberous Sclerosis Association (TSA) Chief Executive Louise Fish said: “One in every two people living with TSC-related epileptic seizures has difficult to treat epilepsy that does not respond to traditional anti-epileptic drugs. TSC is typically diagnosed in childhood. (5)

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

TheAnswerPage

MAY 6, 2022

American Epilepsy Society (AES): Written Comments to Norman E. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019.

Epilepsy 52

Epilepsy Food Data Oil 52

Veriheal

NOVEMBER 18, 2022

Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined. In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program.

Edibles 86

Edibles Hemp Epilepsy Programs 86

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

MedicalJane

JUNE 12, 2020

Primary conditions included neurological diseases such as MS and epilepsy, chronic pain from autoimmune diseases like fibromyalgia, back pain, cancer, insomnia, and psychiatric disorders such as anxiety, depression, and PTSD.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

TheAnswerPage

AUGUST 5, 2021

American Epilepsy Society (AES): Written Comments to Norman E. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019.

Epilepsy 52

Epilepsy Food Data Oil 52

TheAnswerPage

MAY 31, 2021

American Epilepsy Society (AES): Written Comments to Norman E. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019.

Epilepsy 52

Epilepsy Food Data Oil 52

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 The organization will focus on the use of special treatment schemes.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

MAY 26, 2022

The move comes as the ministry in June 2021 compiled a report recommending that the government allow the use of drugs that contain substances of marijuana to treat refractory epilepsy as the United States and other countries have approved such medications. This summer, the ministry plans to draft proposals to revise the Cannabis Control Law.

Legalization 52

Legalization Marijuana Epilepsy THC 52

Cannabis Law Report

JANUARY 16, 2022

Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Medicinal Marijuana Association

FEBRUARY 10, 2024

Implement research findings by consulting experts and translating data into practical actions. Research methodologies in cannabis studies can vary from observational studies that simply observe and report data, to randomized controlled trials that provide more robust evidence.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

The Joint Blog

JULY 17, 2020

According to a new study published in the journal Seminars in Pediatric Neurology, marijuana-based products are associated with improvements in the symptoms of autistic patients who have self-injurious behaviors and co-morbid epilepsy. Those diagnosed with both ASD and epilepsy saw a 91% seizure control improvement.

Epilepsy 47

Epilepsy Research and Development Marijuana Treatment 47

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Canna Law Blog

NOVEMBER 29, 2019

Epidiolex is used to treat epilepsy and requires a prescription. I don’t doubt that the FDA based its above conclusions regarding Hemp-CBD on some set of studies or other data set, but it’s hard to justify the FDA making these claims without any reference to how the FDA reached these conclusions. Consumer Update. Conclusion.

Hemp 136

Hemp CBD Data Food 136

The Cannigma

OCTOBER 21, 2021

As per usual, more data is needed. Epilepsy is the most obvious example, where the ketogenic diet has been applied for 100 years, cannabis has long been treated as is now also an FDA-approved treatment for a number of seizure disorders. The keto-canna connection: what do keto and cannabis have in common?

Cannabinoids 143

Cannabinoids Edibles Conditions Data 143

Project CBD

MARCH 21, 2023

While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” A review of the current literature.” And its conclusion?

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

AUGUST 24, 2019

The report reveals… MGC Pharmaceuticals is set to kick off a controlled trial to discover if its medical cannabis product for the treatment of drug-resistant epilepsy has any impact on driving performance.

Epilepsy 45

Epilepsy Pharmaceutical Data Safety 45

The Cannigma

JULY 17, 2022

Realm of Caring was founded in 2013 by two mothers whose children had epilepsy (the daughter of one of the founders was the namesake for Charlotte’s Web CBD.) The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 120

Advocacy Education Events Epilepsy 120

Freedom Leaf

OCTOBER 15, 2018

On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9 billion by 2022.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

JULY 25, 2022

Although a lot of research is being conducted on the subject, no conclusive medical data has been provided to the medical community. Some of the most common findings were that patients experienced relief with conditions and symptoms such as inflammation, severe nausea, insomnia, loss of appetite, muscle spasms, epilepsy, and many more.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

MMJ Recs

NOVEMBER 17, 2023

MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more. Seizure Control: For patients with epilepsy and seizure disorders, certain cannabis-based treatments have shown remarkable effectiveness in reducing the frequency and severity of seizures.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

SpeedWeed

MARCH 27, 2021

Data from Ireland’s Central Statistics Office shows that seizures of marijuana have soared during the pandemic. . According to police data, dealers have turned to different methodologies to unload their stock, like relying more on the postal service to move product. million USD) worth of cannabis.

Data 52

Data Epilepsy Legislation Cannabis 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Canna Care Docs

DECEMBER 16, 2020

Although the data is still growing, small studies and anecdotal evidence seem promising for medical marijuana as treatment for psychiatric disorders like depression, anxiety and PTSD. Research is ongoing, but the existing data and anecdotal reports show potential. Psychiatric disorders like depression, anxiety, and PTSD.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52